In the pharmaceutical industry, protecting data, intellectual property, and research operations is paramount. These CISOs oversee global cybersecurity programs that balance regulatory compliance with innovation, ensuring that critical information systems remain secure while supporting life-saving drug development. Their leadership drives resilient, proactive, and forward-looking strategies that safeguard both patients and the organization’s ability to deliver healthcare solutions worldwide.
Gary Harbison — SVP, Global CISO, Johnson & Johnson
Gary Harbison is a seasoned cybersecurity leader with over 21 years of IT experience, including nearly two decades focused on information security. At Johnson & Johnson, he develops and drives global security strategy, risk management, and compliance programs that protect sensitive data, intellectual property, and critical operations across highly regulated healthcare markets. Gary has built high-performing teams that integrate security into business objectives, ensuring secure operations while enabling innovation. His expertise spans PCI, HIPAA, and privacy programs, as well as business continuity and cyber threat intelligence. Gary also advises cybersecurity startups and serves on executive advisory boards, sharing insights on global risk, regulatory compliance, and emerging threats. His leadership ensures that J&J maintains operational resilience while advancing digital transformation and patient-focused initiatives.
Michael Elmore — SVP & Global CISO, GSK
Michael Elmore oversees cybersecurity strategy for GSK’s global operations, including multi-cloud infrastructure, enterprise risk, and digital transformation initiatives. Previously, he led the Cyber Security Office for Haleon and served as Global CISO at Cigna Healthcare. Michael has extensive experience driving M&A transitions, building NIST-CSF-aligned programs, and cultivating risk-aware cultures. He is skilled in integrating security across IT, OT, applications, and customer-facing systems while anticipating emerging threats such as AI risks and post-quantum cryptography. Michael also advises venture capital and startup firms, sharing strategic insights into infrastructure and cybersecurity advancements. He is committed to balancing innovation with resilience, ensuring GSK’s systems remain secure, scalable, and aligned with business goals while safeguarding patient data and global operations.
Frederic Lancaster — Global Head of Cybersecurity, AstraZeneca
Frederic Lancaster is responsible for AstraZeneca’s global cybersecurity strategy, leading teams across China, Japan, LATAM, the EU, and the US. He focuses on driving innovation, mitigating risk, and protecting patient data in a complex, highly regulated environment. Frederic emphasizes disruption and operational efficiency, building high-performing teams that integrate security into business processes. He promotes digital trust and resilient practices while challenging outdated cybersecurity approaches. Frederic’s leadership blends technical expertise with visionary strategy, ensuring AstraZeneca maintains a proactive security posture while enabling rapid global growth and innovation in pharmaceuticals.
Adrian Stone — Chief Technology & Information Security Officer, SVP, Moderna
Adrian Stone manages Moderna’s global cybersecurity and core technology infrastructure. He oversees networks, enterprise systems, OT, collaboration services, and cloud engineering, ensuring secure, scalable operations for tens of thousands of employees and partners. Adrian also drives AI integration across technology platforms while aligning enterprise risk management with corporate strategy. He partners with the Board of Directors, providing insights on resilience, risk posture, and emerging threats. With nearly 30 years of experience, Adrian’s leadership ensures Moderna’s systems protect critical operations while supporting its mission to deliver transformative mRNA-based therapies worldwide.
Michael Daly — VP & CISO, Vertex Pharmaceuticals
Michael Daly brings deep experience in enterprise cybersecurity and technology operations. At Vertex, he leads initiatives to protect sensitive clinical, operational, and financial data while ensuring regulatory compliance. He specializes in security policy, enterprise architecture, vulnerability management, systems engineering, and IT strategy, building robust programs that scale across global operations. Michael’s guidance ensures that Vertex maintains operational continuity, mitigates emerging cyber threats, and integrates security into business transformation efforts.
Pete Naumovski — Global CISO & VP of IT Risk Management, AbbVie
Pete Naumovski is an accomplished cyber executive with 18 years of experience building security programs for global organizations. At AbbVie, he leads risk management, compliance, and cybersecurity strategy, fostering a culture of security awareness and resilience. Pete integrates technology, processes, and governance to protect critical intellectual property and patient data. His approach emphasizes proactive threat detection, regulatory alignment, and operational continuity, ensuring AbbVie’s global operations are secure and adaptive in an evolving threat landscape.
Guardians of Health Data and Innovation
Pharmaceutical CISOs protect critical patient information, clinical data, and proprietary research in highly regulated environments. These leaders blend technical expertise, regulatory compliance, and strategic vision to ensure that global operations remain secure while enabling innovation. By embedding cybersecurity into organizational culture, they safeguard lives, intellectual property, and trust while supporting the development of transformative therapies and medical advancements.